Synthetic biology poses few risks because it is still in its early stages and there is no need to impose new restrictions on, or temporarily halt, this type of research, says a report being released Thursday by the Presidential Commission for the Study of Bioethical Issues.
The Synthetic Biology Newsletter is an initiative of LIS Consult and the Synthetic Biology Project of the Woodrow Wilson International Center for Scholars. The newsletter is financially supported by the Commission on Genetic Modification and the Rathenau Institute, both in the Netherlands.
Workshop hosted by the Alfred R. Sloan Foundation, the U.S. Department of Energy, and the Woodrow Wilson International Center for Scholars
November 8-9, 2010
A new Eurobarometer survey on life sciences and biotechnology shows that Europeans are optimistic about biotechnology. 53% of respondents believe biotechnology will have a positive effect in the future, and only 20% a negative effect.
Regarding the specifics of synthetic biology, Science Daily wrote in a Nov. 5, 2010 press release, “The University of Greenwich’s School of Architecture & Construction is poised to use ethical synthetic biology to create ‘living’ materials that could be used to clad buildings and help combat the effects of climate change.
Super Cell is a fictional supermarket offering speculative products, which are all based on synthetic biology.
Three international drug companies have announced strategic moves to strengthen their position in the booming Chinese health care market.
College and high school students from the world over begin convening in Boston today for the International Genetically Engineered Machine (iGEM) competition to present biotech projects they’ve been working on all summer.
Researchers are working with the University of Southern Denmark, theUniversity of Glasgow and University College London (UCL) to develop building materials that could produce water in desert environments or harvest sunlight to make biofuels.
Synthetic Genomics (SGI) and the J. Craig Venter Institute (JCVI) have formed a new company, Synthetic Genomics Vaccines (SGVI), to develop next-generation vaccines based on synthetic genome technology.
New Yorkers brought in the autumnal equinox in style September 25th and 26th at the 2010 Maker Faire.
How much should synthetic biology – the design and construction of new biological parts, devices and systems, and the redesign of existing, natural biological systems for useful purposes – be regulated? And by whom?